Human Papillomavirus 31/33 (HPV 31/33), DNA [Real-Time PCR]

The method allows for the qualitative determination of viral DNA in the test material (urogenital smear, biopsy specimen). The test is of great importance in confirming the diagnosis of the disease, determining further treatment tactics, and evaluating the effectiveness of the therapy being conducted. Virus genotypes 31 and 33 are oncogenic, therefore early detection of the infection is of great importance in terms of determining the prognosis and timely prescription of adequate therapy.

Within 3 days. The specified time does not include the day of biomaterial collection